Zhongzhi Pharmaceutical Holdings Limited provided consolidated earnings guidance for the year ended December 31, 2022. It is expected that the Group will record a significant increase in the net profit with net profit of around RMB 110.0 million for Fiscal 2022 as compared to the net profit of approximately RMB 52.4 million for the year ended 31 December 2021 (Fiscal 2021).